0000000000070816
AUTHOR
Averna Mr
showing 18 related works from this author
A Novel HPLC-MS Method for Analysis of Plasma Sterols
2006
No association of Cystatin C Polymorphism I in italian subjects with Alzheimer's disease
2004
Use of the drug eluting stents with rapamicin in patients with anatomical or clinical patterns favouring restenosis: results of a 6-months follow-up …
2004
PEAK PARTICLE SIZE AND THE EXTENSION OF CORONARY ATHEROSCLEROSIS IN 71 PATIENTS THAT UNDERWENT AN ANGIOGRAPHIC EXAM
2004
EFFETTI “BEYOND CHOLESTEROL” DELLE STATINE
2004
NOVEL NONSENSE MUTATION IN THE CETP GENE IN ITALIAN HYPERALPHALIPOPROTEINEMIC SUBJECTS
2005
Lack of association of low density lipoprotein receptor-related protein gene exon 3 polymorphism in italian subjects with Alzheimer's disease
2004
Variazioni emodinamiche del circolo epatico in pazienti con bright liver ecopattern e sindrome metabolica
2007
ASSOCIATION OF PARAOXONASE-1 Q192R PLYMORPHISM WITH CORONARY ARTERY DISEASE IN AMI PATIENTS, NON AMI CAD PATIENTS AND HEALTHY CONTROLS
2005
Genetic heterogeneity of familial hypercholesterolemia in Sicily
2006
Association between the apolipoprotein e4 allele and apathy in probable Alzheimer's disease
2004
Alteraziioni morfofunzionali vascolari in una popolazione con sindrome metabolica e steatosi epatica ecografica
2007
HDL subfractions distribution in renal transplant recipients: Lack of evidence of a reduction of HDL2 particles
1996
Since the high rate of cardiovascular disease in renal transplant recipients, alterations of lipoprotein profile in such patients were extensively evaluated, but the HDL subclass profile was not completely clarified. Renal transplant recipients usually show normal to high plasma levels of HDL cholesterol, even if some investigations suggested a persistence of low HDL2 levels: this was not useful in terms of cardiovascular protection. We designed this study in order to evaluate HDL subfractions distribution in renal transplant recipients. We studied 55 renal transplant recipients, treated with prednisone, azathioprine and/or cyclosporine, and 34 healthy normolipidemics as controls. In all su…
Le ipocolesterolemie primitive
2007
Hypobetalipoproteinemia (HBL) is characterized by cholesterol levels below the 5th percentile of the population distribution. Familial HBL (FHBL) is characterized by an inherited HBL trait within a family. In the last years gene defects underlying some cases of FHBL, but not all, have been identified. The molecular basis of some gene defect and the clinical onset of FHBL are presented in this paper.